Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Malka

Showing results (71-80 of 192) with videos related to

Pageof 20
Sort By:
Investigational New Drugs|April 22, 2014
Gemcitabine and oxaliplatin chemotherapy for advanced hepatocellular carcinoma after failure of anti-angiogenic therapiesAnna Patrikidou, Isabelle Sinapi, Hélène Regnault, et al.
Journal of Vascular and Interventional Radiology : JVIR|October 30, 2010
Percutaneous femoral implantation of an arterial port catheter for intraarterial chemotherapy: feasibility and predictive factors of long-term functionalityFrederic Deschamps, Pramod Rao, Christophe Teriitehau, et al.
Gastroenterologie Clinique Et Biologique|March 31, 2007
Sentinel lymph nodes of colorectal carcinoma: reappraisal of 123 casesGabriel Liberale, Philippe Lasser, Jean-Christophe Sabourin, et al.
Therapeutic Advances in Medical Oncology|June 28, 2019
Molecular targeted therapy of <i>BRAF</i>-mutant colorectal cancerMichel Ducreux, Ali Chamseddine, Pierre Laurent-Puig, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 10, 2009
The long-term impact of hyperthermic intraperitoneal chemotherapy on survivors treated for peritoneal carcinomatosis: a cross-sectional studyFranck Zenasni, Marion Botella, Dominique Elias, et al.
Seminars in Oncology|January 15, 2019
Systemic treatment of pancreatic cancer revisitedMichel Ducreux, Thomas Seufferlein, Jean-Luc Van Laethem, et al.
Cancers|April 30, 2021
Upper Gastrointestinal Lesions during Endoscopy Surveillance in Patients with Lynch Syndrome: A Multicentre Cohort StudyRomain Chautard, David Malka, Elia Samaha, et al.
Cancer|March 23, 2011
Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: a multicenter AGEO studyAziz Zaanan, Mélanie Gauthier, David Malka, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 25, 2018
Modified FOLFIRINOX versus CisGem first-line chemotherapy for locally advanced non resectable or metastatic biliary tract cancer (AMEBICA)-PRODIGE 38: Study protocol for a randomized controlled multicenter phase II/III studyJean-Marc Phelip, Julien Edeline, Jean-Frédéric Blanc, et al.
Cancers|June 24, 2022
Safety and Efficacy of Bevacizumab in Cancer Patients with Inflammatory Bowel DiseaseRuth Gabriela Herrera-Gómez, Miruna Grecea, Claire Gallois, et al.
Pageof 20

Showing results (71-80 of 192) with videos related to

Sort By:
Pageof 20
Investigational New Drugs|April 22, 2014
Gemcitabine and oxaliplatin chemotherapy for advanced hepatocellular carcinoma after failure of anti-angiogenic therapiesAnna Patrikidou, Isabelle Sinapi, Hélène Regnault, et al.
Journal of Vascular and Interventional Radiology : JVIR|October 30, 2010
Percutaneous femoral implantation of an arterial port catheter for intraarterial chemotherapy: feasibility and predictive factors of long-term functionalityFrederic Deschamps, Pramod Rao, Christophe Teriitehau, et al.
Gastroenterologie Clinique Et Biologique|March 31, 2007
Sentinel lymph nodes of colorectal carcinoma: reappraisal of 123 casesGabriel Liberale, Philippe Lasser, Jean-Christophe Sabourin, et al.
Therapeutic Advances in Medical Oncology|June 28, 2019
Molecular targeted therapy of <i>BRAF</i>-mutant colorectal cancerMichel Ducreux, Ali Chamseddine, Pierre Laurent-Puig, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 10, 2009
The long-term impact of hyperthermic intraperitoneal chemotherapy on survivors treated for peritoneal carcinomatosis: a cross-sectional studyFranck Zenasni, Marion Botella, Dominique Elias, et al.
Seminars in Oncology|January 15, 2019
Systemic treatment of pancreatic cancer revisitedMichel Ducreux, Thomas Seufferlein, Jean-Luc Van Laethem, et al.
Cancers|April 30, 2021
Upper Gastrointestinal Lesions during Endoscopy Surveillance in Patients with Lynch Syndrome: A Multicentre Cohort StudyRomain Chautard, David Malka, Elia Samaha, et al.
Cancer|March 23, 2011
Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: a multicenter AGEO studyAziz Zaanan, Mélanie Gauthier, David Malka, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 25, 2018
Modified FOLFIRINOX versus CisGem first-line chemotherapy for locally advanced non resectable or metastatic biliary tract cancer (AMEBICA)-PRODIGE 38: Study protocol for a randomized controlled multicenter phase II/III studyJean-Marc Phelip, Julien Edeline, Jean-Frédéric Blanc, et al.
Cancers|June 24, 2022
Safety and Efficacy of Bevacizumab in Cancer Patients with Inflammatory Bowel DiseaseRuth Gabriela Herrera-Gómez, Miruna Grecea, Claire Gallois, et al.
Pageof 20